Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

Humoral Immune Responses

Humoral Immune Responses

Affinity and Avidity

Affinity and Avidity

Antibody Structure

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A quantitative systems pharmacology model to inform clinical translation of dynamic PKPD relationships of engineered IL-15.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2025

Same author

Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinations.

EBioMedicine·2025

Same author

Leveraging neonatal Fc receptor (FcRn) to enhance antibody transport across the blood brain barrier.

Nature communications·2025

Same author

A B7-H3-Targeted CD28 Bispecific Antibody Enhances the Activity of Anti-PD-1 and CD3 T-cell Engager Immunotherapies.

Molecular cancer therapeutics·2024

Same author

Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy.

Frontiers in pharmacology·2024

Same author

i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists.

Nature communications·2024

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

Modulation of antibody effector function.

John R Desjarlais¹, Greg A Lazar

¹Xencor, Inc, Monrovia, CA 91016, USA. jrd@xencor.com

Experimental Cell Research

|April 5, 2011

Summary

This summary is machine-generated.

New antibody engineering technologies enhance immune responses by modifying the Fc domain. These advances, validated in animal and human studies, improve antibody effector functions.

More Related Videos

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

Related Experiment Videos

Last Updated: Jun 3, 2026

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay

Published on: September 7, 2018

Area of Science:

Immunology
Biotechnology
Antibody Engineering

Background:

Antibody effector functions are crucial for therapeutic efficacy.
The constant Fc domain mediates interactions with immune cells.
Enhancing antibody functions is a key goal in drug development.

Purpose of the Study:

To review novel technologies for antibody Fc domain modification.
To discuss methods for enhancing antibody effector functions.
To evaluate the clinical and preclinical validation of these technologies.

Main Methods:

Review of recent scientific literature on antibody engineering.
Analysis of studies focusing on Fc domain modifications (amino acid substitutions, glycoengineering).
Examination of data from animal models and human clinical trials.

Main Results:

Several novel technologies have emerged for antibody Fc engineering.
These technologies modulate Fc receptor interactions and effector cell engagement.
Validation data from preclinical and clinical studies support the efficacy of these modifications.

Conclusions:

Fc domain engineering offers promising strategies to enhance antibody-mediated therapies.
Validated technologies can improve the therapeutic potential of antibodies.
Further development in this area holds significant therapeutic promise.